Medicare
-
{
- All
- News
- Videos
-
Trump Pledges $90 Medicare Premium Each To 20 Million Seniors
- Sunday October 4, 2026
- World News | Associated Press
That pledge - which would require approval from Congress - would likely cost more than $1 trillion, adding to the deficit and worsening inflation.
-
www.ndtv.com
-
US Drug Prices See Biggest Drop In 63 Years, Says Medicare Chief
- Monday August 24, 2026
- Health | Indo Asian News Service
US prescription drug prices are falling at their fastest rate in 63 years and are likely to decline further, the Trump administration's Medicare Chief said on Sunday.
-
www.ndtv.com/health
-
What Happens When Your Hospital Is Also Your Insurance Company? We're Starting To See The Effects
- Tuesday August 18, 2026
- Health | Written by Geronimo Bejarano Cardenas
Health plans that are owned by hospitals have sprung up in many insurance markets, including commercial insurance, Medicaid, which is largely managed by states, and Medicare Advantage. Medicare Advantage is the private alternative to the traditional Medicare program.
-
www.ndtv.com/health
-
Buy, Sell Or Hold: Sona BLW, Vodafone Idea, Shivalik Bimetal, Shilpa Medicare — Ask Profit
- Thursday December 25, 2025
- Author: Khushi Maheshwari
Kush Bohra, the founder of kushbbora.com and CA Tapan Doshi, research analyst at catapan provided insights on investor queries and more on NDTV Profit's Ask Profit show.
-
www.ndtvprofit.com
-
Indian National Gets 2 Years Jail For $1.17 Million US Medicare Fraud
- Wednesday December 3, 2025
- World News | Indo-Asian News Service
An Indian national who admitted to orchestrating a multimillion-dollar Medicare fraud through a Washington-based diagnostic lab was sentenced to two years in federal prison, US Attorney Charles Neil Floyd announced.
-
www.ndtv.com
-
Stocks To Buy: Sun Pharma, Cipla, Rainbow Among Systematix Top Picks In Healthcare Space Post Q2 Results
- Monday November 24, 2025
- Author: Systematix Institutional Equities
Systematix’s top picks for the sector include Sun Pharma, Cipla, Ajanta Pharma among others - Check full list.
-
www.ndtvprofit.com
-
Rainbow Children’s Medicare Gets Systematix 'Buy' On Coverage Initiation— Check Target Price
- Thursday October 9, 2025
- Author: Systematix Institutional Equities
Rainbow is aptly placed to benefit from the structural transition of paediatric care from general hospital wards to specialty hospitals, adds the brokerage.
-
www.ndtvprofit.com
-
Bonus Shares Record Date This Week — GEE, Paushak, Shilpa Medicare
- Sunday September 28, 2025
- Author: Prajwal Jayaraj
To be eligible for a bonus issue, investors should pay attention to the record date, which is used to determine eligible shareholders.
-
www.ndtvprofit.com
-
'Buy' Sun Pharma, Cipla; 'Hold' Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results
- Wednesday April 16, 2025
- Author: Systematix Institutional Equities
Systematix expects select companies in the US to benefit from the ramp up in generic Revlimid like Zydus Life and Sun Pharmaceuticals.
-
www.ndtvprofit.com
-
Shilpa Medicare Gets 'Buy' Rating As Systematix Initiates Coverage, Sets Target Price Of Rs 857
- Friday February 14, 2025
- Author: Systematix Institutional Equities
The brokerage believe Shilpa Medicare’s differentiated / CRAMS portfolio would help the company to deliver high-teen revenue growth and disproportionate profit expansion.
-
www.ndtvprofit.com
-
Trump Pledges $90 Medicare Premium Each To 20 Million Seniors
- Sunday October 4, 2026
- World News | Associated Press
That pledge - which would require approval from Congress - would likely cost more than $1 trillion, adding to the deficit and worsening inflation.
-
www.ndtv.com
-
US Drug Prices See Biggest Drop In 63 Years, Says Medicare Chief
- Monday August 24, 2026
- Health | Indo Asian News Service
US prescription drug prices are falling at their fastest rate in 63 years and are likely to decline further, the Trump administration's Medicare Chief said on Sunday.
-
www.ndtv.com/health
-
What Happens When Your Hospital Is Also Your Insurance Company? We're Starting To See The Effects
- Tuesday August 18, 2026
- Health | Written by Geronimo Bejarano Cardenas
Health plans that are owned by hospitals have sprung up in many insurance markets, including commercial insurance, Medicaid, which is largely managed by states, and Medicare Advantage. Medicare Advantage is the private alternative to the traditional Medicare program.
-
www.ndtv.com/health
-
Buy, Sell Or Hold: Sona BLW, Vodafone Idea, Shivalik Bimetal, Shilpa Medicare — Ask Profit
- Thursday December 25, 2025
- Author: Khushi Maheshwari
Kush Bohra, the founder of kushbbora.com and CA Tapan Doshi, research analyst at catapan provided insights on investor queries and more on NDTV Profit's Ask Profit show.
-
www.ndtvprofit.com
-
Indian National Gets 2 Years Jail For $1.17 Million US Medicare Fraud
- Wednesday December 3, 2025
- World News | Indo-Asian News Service
An Indian national who admitted to orchestrating a multimillion-dollar Medicare fraud through a Washington-based diagnostic lab was sentenced to two years in federal prison, US Attorney Charles Neil Floyd announced.
-
www.ndtv.com
-
Stocks To Buy: Sun Pharma, Cipla, Rainbow Among Systematix Top Picks In Healthcare Space Post Q2 Results
- Monday November 24, 2025
- Author: Systematix Institutional Equities
Systematix’s top picks for the sector include Sun Pharma, Cipla, Ajanta Pharma among others - Check full list.
-
www.ndtvprofit.com
-
Rainbow Children’s Medicare Gets Systematix 'Buy' On Coverage Initiation— Check Target Price
- Thursday October 9, 2025
- Author: Systematix Institutional Equities
Rainbow is aptly placed to benefit from the structural transition of paediatric care from general hospital wards to specialty hospitals, adds the brokerage.
-
www.ndtvprofit.com
-
Bonus Shares Record Date This Week — GEE, Paushak, Shilpa Medicare
- Sunday September 28, 2025
- Author: Prajwal Jayaraj
To be eligible for a bonus issue, investors should pay attention to the record date, which is used to determine eligible shareholders.
-
www.ndtvprofit.com
-
'Buy' Sun Pharma, Cipla; 'Hold' Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results
- Wednesday April 16, 2025
- Author: Systematix Institutional Equities
Systematix expects select companies in the US to benefit from the ramp up in generic Revlimid like Zydus Life and Sun Pharmaceuticals.
-
www.ndtvprofit.com
-
Shilpa Medicare Gets 'Buy' Rating As Systematix Initiates Coverage, Sets Target Price Of Rs 857
- Friday February 14, 2025
- Author: Systematix Institutional Equities
The brokerage believe Shilpa Medicare’s differentiated / CRAMS portfolio would help the company to deliver high-teen revenue growth and disproportionate profit expansion.
-
www.ndtvprofit.com